Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 20:15 | 2026-03-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.93 | 15,624 | $14,530 | 72,048 | -17.8% |
| 2026-01-03 00:37 | 2025-12-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $1.13 | 15,715 | $17,758 | 87,672 | -15.2% |
| 2025-09-30 23:14 | 2025-09-29 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $1.58 | 15,677 | $24,770 | 103,387 | -13.2% |
| 2025-07-02 23:15 | 2025-06-30 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $1.23 | 15,701 | $19,312 | 119,064 | -11.7% |
| 2025-04-02 23:16 | 2025-03-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.92 | 3,004 | $2,764 | 22,886 | -11.6% |
| 2025-01-04 00:15 | 2024-12-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $2.67 | 3,006 | $8,026 | 25,890 | -10.4% |
| 2024-10-02 23:22 | 2024-09-30 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $4.95 | 2,993 | $14,815 | 28,896 | -9.4% |
| 2024-07-02 14:15 | 2024-06-28 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $6.41 | 2,986 | $19,140 | 31,889 | -8.6% |
| 2024-06-13 03:34 | 2024-06-10 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $9.94 | 3,707 | $36,848 | 34,875 | -9.6% |
| 2024-01-03 02:33 | 2023-12-29 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $6.68 | 3,713 | $24,803 | 17,042 | -17.9% |
| 2023-11-23 00:03 | 2023-11-20 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.81 | 38,502 | $31,187 | 207,562 | -15.6% |
| 2023-09-07 04:01 | 2023-09-01 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.71 | 38,963 | $27,664 | 246,064 | -13.7% |
| 2023-07-08 04:46 | 2023-06-27 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.62 | 3,872 | $2,401 | 17,170 | -18.4% |
| 2022-12-31 03:09 | 2022-12-28 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $2.97 | 3,733 | $11,087 | 19,679 | -15.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.